Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioequivalence review for drug interchangeability.

S C Chow1, J Shao

  • 1StatPlus, Inc., Yardley, Pennsylvania 19067, USA.

Journal of Biopharmaceutical Statistics
|September 3, 1999
PubMed
Summary

This study introduces new methods to assess bioequivalence between generic drugs and brand-name drugs. These approaches enhance statistical power for monitoring generic drug performance and ensuring therapeutic equivalence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

[Impact of father involvement in childcare on maternal parenting stress for children aged 6 to 24 months in rural areas of Zhejiang Province].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

[Safety study of navigation-assisted medial "in-out-in" technique in C<sub>2</sub> screw fixation].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

[The clinical effect of three dimensional print guided F/B-TEVAR vascular endoluminal repair of anastomotic leaks after open surgery for type A aortic dissection].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

[Prevalence of sarcopenia and influencing factors in middle-aged and older adults in Zhejiang Province].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025
Same author

[Development of a grading diagnostic model for schistosomiasis-induced liver fibrosis based on radiomics and clinical laboratory indicators].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2024

Area of Science:

  • Pharmacokinetics and Drug Development
  • Biostatistics
  • Pharmaceutical Sciences

Background:

  • Ensuring therapeutic equivalence between generic and brand-name drugs is crucial for patient safety and healthcare economics.
  • Standard bioequivalence studies (2x2 crossover) are essential for drug approval but may have limitations in statistical power for comparative analysis.
  • Monitoring the performance of multiple generic drug copies requires robust statistical methodologies.

Purpose of the Study:

  • To propose and evaluate statistical methods for assessing bioequivalence among multiple generic drug copies and their reference brand-name drug.
  • To enhance the statistical power of bioequivalence assessments, particularly when between-subject variability is not substantial.
  • To provide a framework for monitoring the comparative performance of generic drugs post-approval.

Main Methods:

  • Development of a meta-analysis approach to pool data from multiple bioequivalence studies.
  • Consideration of a non-meta-analysis method for direct comparison.
  • Application of proposed methods to a numerical example using standard 2x2 crossover bioequivalence study data without carryover effects.

Main Results:

  • The proposed meta-analysis method demonstrates increased statistical power for bioequivalence assessment under specific conditions (low between-subject variability).
  • Both meta-analysis and non-meta-analysis methods provide frameworks for comparing generic drugs against the brand-name drug and among themselves.
  • The numerical example illustrates the practical application and potential benefits of the developed statistical techniques.

Conclusions:

  • The proposed statistical methods, particularly meta-analysis, offer a powerful tool for monitoring the bioequivalence of generic drugs.
  • These methods can improve the assessment of drug performance and support regulatory decisions regarding generic drug approvals and market surveillance.
  • Further application of these techniques can enhance confidence in the therapeutic equivalence of generic medications.

Related Experiment Videos